Equibles does not estimate personal net worth.
Get an email with a short summary when Vireo Growth Inc. publishes a filing, an earnings call transcript or a press release.
Get VREOF alertsDr. Kyle E. Kingsley is recorded as Chairman and Board Member at Vireo Growth Inc. (VREOF) since January 1, 2019. The newest filing on record that lists Dr. Kyle E. Kingsley as Board Member at Vireo Growth Inc. (VREOF) is dated April 16, 2026. The newest filing on record that lists Dr. Kyle E. Kingsley as Chairman at Vireo Growth Inc. (VREOF) is dated May 9, 2025. Vireo Growth Inc. reported in an 8-K filed February 17, 2023 that Dr. Kyle E. Kingsley was appointed Executive Chairman, effective February 14, 2023. Vireo Growth Inc. reported in an 8-K filed February 17, 2023 that Dr. Kyle E. Kingsley resigned as Chief Executive Officer, effective February 14, 2023. The proxy statement of Vireo Growth Inc. reports total compensation of $2,020,000 for Dr. Kyle E. Kingsley in fiscal 2024, including a base salary of $270,000. Disclosed compensation is on record for 5 fiscal years. Vireo Growth Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Vireo Growth Inc. includes Amber H. Shimpa (CEO), Amber Shimpa (CEO), John Mazarakis (CEO, Chairman and Board Member) and 7 others.
“Dr. Kyle E. Kingsley, age 47, has been appointed to the position of Executive Chairman and has resigned the position of Chief Executive Officer ("CEO") of both the Registrant and its wholly-owned subsidiary, Vireo Health, Inc. ("VHI").”
“Dr. Kyle E. Kingsley, age 47, has been appointed to the position of Executive Chairman and has resigned the position of Chief Executive Officer ("CEO") of both the Registrant and its wholly-owned subsidiary, Vireo Health, Inc. ("VHI").”
2019-01-01–present
Last confirmed May 9, 2025
2019-01-01–present
Last confirmed April 16, 2026
Proxy statement
Start not stated–present
Last confirmed April 16, 2026
Start not stated–2023-02-14
VREOF
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman, Board Member
2019-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Vireo Growth Inc. (VREOF) | Co-Executive Chairman | $270,000 | $2,020,000 |
| 2023 | Vireo Growth Inc. (VREOF) | Co-Executive Chairman | $275,000 | $957,432 |
| 2022 | Vireo Growth Inc. (VREOF) | Former Chief Executive Officer and Executive Chair of the Board | $360,000 | $1,591,041 |
| 2021 | Vireo Growth Inc. (VREOF) | Chief Executive Officer | $360,000 | $360,176 |
| 2020 | Vireo Growth Inc. (VREOF) | Chief Executive Officer | $295,269 | $295,445 |
